Jeffrey Chodakewitz

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Scott M. Hammer, Kathleen Squires, Michael D. Hughes et al. · New England Journal of Medicine · 1997 · 2.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Roy M. Gulick, John W. Mellors, Diane V. Havlir et al. · New England Journal of Medicine · 1997 · 1.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Susan Buchbinder, Devan V. Mehrotra, Ann Duerr et al. · The Lancet · 2008 · 1.7K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

Rajesh Krishna, Matt S. Anderson, Arthur Bergman et al. · The Lancet · 2007 · 277 citations

Life Sciences, Pharmacology, Pharmacotherapy +15

Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection

Roy M. Gulick, John W. Mellors, Diane V. Havlir et al. · JAMA · 1998 · 239 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16